TMEM106B and frontotemporal dementia: TMEM106B has been identified as a genetic modifier in FTD, modulating the age at disease onset in frontotemporal lobar degeneration–TDP-43 disease (Cruchaga et al., 2011; Gallagher et al., 2014; van Blitterswijk et al., 2014).